BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38537311)

  • 1. Impact of iodinated oil in proton therapy on relative stopping power of liver post-cTACE.
    Shu J; Zhang J; Jee K; Liu L; Hu M; Huo W; Cui X; Wang H; Lu HM
    Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537311
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of real tissue water equivalent path lengths using an efficient dose extinction method.
    Zhang R; Baer E; Jee KW; Sharp GC; Flanz J; Lu HM
    Phys Med Biol; 2017 Jun; 62(14):5640-5651. PubMed ID: 28644820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of proton beam range uncertainty in breast treatment using tissue samples.
    Cui X; Jee K; Hu M; Bao J; Lu HM
    Phys Med Biol; 2022 Dec; 67(24):. PubMed ID: 36379067
    [No Abstract]   [Full Text] [Related]  

  • 4. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
    Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial.
    Letzen BS; Malpani R; Miszczuk M; de Ruiter QMB; Petty CW; Rexha I; Nezami N; Laage-Gaupp F; Lin M; Schlachter TR; Chapiro J
    Clin Imaging; 2021 Oct; 78():194-200. PubMed ID: 34022765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
    AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
    Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
    Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of beam-hardening corrections on proton relative stopping power estimates from single- and dual-energy CT.
    Chacko MS; Wu D; Grewal HS; Sonnad JR
    J Appl Clin Med Phys; 2022 Sep; 23(9):e13711. PubMed ID: 35816460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
    Savic LJ; Chapiro J; Funai E; Bousabarah K; Schobert IT; Isufi E; Geschwind JH; Stark S; He P; Rudek MA; Perez Lozada JC; Ayyagari R; Pollak J; Schlachter T
    Eur Radiol; 2021 May; 31(5):3002-3014. PubMed ID: 33063185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE).
    de Baere T; Ronot M; Chung JW; Golfieri R; Kloeckner R; Park JW; Gebauer B; Kibriya N; Ananthakrishnan G; Miyayama S
    Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1430-1440. PubMed ID: 35978174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental comparison of relative stopping power evaluation between proton CT and x-ray CT for pre-clinical proton irradiation studies of small animals.
    Terakawa A; Hosokawa H; Nogami M; Hitomi K; Ishii K
    Phys Med Biol; 2023 Apr; 68(9):. PubMed ID: 37011626
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma.
    Langenbach MC; Vogl TJ; Said G; Scholtz JE; Hammerstingl R; Gruber-Rouh T
    Cancer Biother Radiopharm; 2024 Apr; 39(3):196-202. PubMed ID: 33481646
    [No Abstract]   [Full Text] [Related]  

  • 14. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE.
    Hu B; Zhong BY; Zhang L; Dai C; Li W; Shen J; Huang P; Zhang S; Li Z; Ni CF
    Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1460-1467. PubMed ID: 32500251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-comparison of relative stopping power estimation models for proton therapy.
    Doolan PJ; Collins-Fekete CA; Dias MF; Ruggieri TA; D'Souza D; Seco J
    Phys Med Biol; 2016 Nov; 61(22):8085-8104. PubMed ID: 27781999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical Note: Relative proton stopping power estimation from virtual monoenergetic images reconstructed from dual-layer computed tomography.
    Landry G; Dörringer F; Si-Mohamed S; Douek P; Abascal JFPJ; Peyrin F; Almeida IP; Verhaegen F; Rinaldi I; Parodi K; Rit S
    Med Phys; 2019 Apr; 46(4):1821-1828. PubMed ID: 30695108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting early necrosis of colorectal liver metastases using volumetric enhancement on baseline MRI and oil deposition on post-cTACE unenhanced CT.
    Hazhirkarzar B; Tang H; Ghadimi M; Baghdadi A; Motaghi M; Wu Q; Shaghaghi M; Kamel I
    Abdom Radiol (NY); 2021 Oct; 46(10):4610-4618. PubMed ID: 34089068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
    BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
    Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
    Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of energy-resolved dose imaging technique in pencil beam scanning mode.
    Alaka BG; Bentefour EH; Chirvase C; Samuel D; Teo BK
    Biomed Phys Eng Express; 2020 Sep; 6(6):. PubMed ID: 35102004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.